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care. We aimed to overview physicians’ management of acute and stable asthma and
chronic obstructive lung disease (COPD) in the Nordic countries based on scientific
reports during the last 10 years.
Strategies to improve asthma management should consider applying more
frequently good quality spirometry in diagnosing asthma and COPD. There still
appear to be an under-use of glucocorticosteroids in acute as well as in stable
disease in the Nordic countries, especially among asthmatic patients. An over
prescription of antibiotics in asthma patients were observed. In COPD patients there
are uncertainty in management with under use of ipratropiumbromid and
inappropriate use of corticosteroids as well as inadequate knowledge about
nebulizing systems, dosing of medicines, monitoring severity of disease and tools
for quality control.
Further improvement may include educational approaches like multidisciplinary
approach for medical students and self-learning groups of doctors. Modern Internet
technology and telemedicine may be new ways to proceed in improving health care
for patients with asthma and COPD.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Failure to follow management guidelines may result
in poor control of disease and reduced quality of life.
The aim of this presentation is to give a report on theElsevier Ltd. All rights reserv
76088; fax: +47 55975536.
lse-bergen.nophysicians’ management of acute and stable asthma
and chronic obstructive lung disease (COPD) in the
Nordic countries. Scientific reports during the last 10
years giving data on asthma or COPD management
have been included. The outcomes reported have
been evaluated according to standards in national
and international guidelines.1–6
When considering management of asthma and
COPD in the community, including diagnosis anded.
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Table 1 Commonly used guidelines for physicians’ management of asthma and COPD in the Nordic countries.
Guideline title Asthma Chronic
obstructive
pulmonary disease
(COPD)
Nordic or local
guideline only
References
Global strategy for asthma
management and prevention
(GINA)
x 6
Global strategy for the diagnosis,
management, and prevention of
chronic obstructive pulmonary
disease (GOLD)
x 5
Nordic Asthma Consensus Group:
Nordic consensus report on
asthma management
x x 4
Danish Pulmonary Society:
Diagnosis and treatment of
chronic obstructive pulmonary
disease
x x 2
Finnish National Guidelines for
Prevention and Treatment
1998–2007: Chronic bronchitis
and chronic obstructive
pulmonary disease
x x 3
Asthma programme in Finland
1994–2004
x x 1
E. Omenaas et al.S32treatment, it is important to consider the total
population of asthma and COPD patients. A problem
is that many clinical studies of high quality include
a very small and highly selected fraction of the
total patient population with problems extrapolat-
ing such data to a larger ‘‘real life’’ population of
patients with obstructive lung disease7 (Table 1).Asthma and COPD
Stable disease—diagnosis
Management of diagnosis of obstructive lung
disease was, based on their own report, evaluated
among 119 general practitioners and 48 hospital
doctors in the county of Hordaland.8 In spite of
recommended guidelines, 20% of the doctors did
not perform any kind of spirometry when diagnos-
ing obstructive pulmonary disease. Spirometry
after inhalation of bronchodilators or corticoster-
oids was performed by 29% of the doctors when
diagnosing chronic obstructive pulmonary disease
and by 43% when diagnosing asthma. In the AIRE
study including patients from seven European
countries, including Sweden, as much as 45% ofthe patients reported that their doctor had never
performed a lung function test.9
National treatment programmes for asthma and
COPD in Finland have in the past few years
increased the need for spirometry.1,10 The quality
of spirometric examinations in Finland had im-
proved from 1990 up to 1998. In 1998, about
400 000 spirometric examination were performed.
The main qualitative insuffiences were related to
preparation of the subjects for the examination,
performance of the test, recognition of a successful
spirometric curve and evaluation of reproducibility
of the examination.10
When focusing on spirometry in the diagnosis of
asthma and COPD in new and updated guidelines
there are some problems to consider. For example,
the risk for over-diagnosis of COPD in those aged
470 years.11 In addition, some groups of subjects
might be more likely to have asthma and COPD12 or
be more likely to experience complications of the
disease.13 Should they be treated with special care?
Additional questions to be asked is: Should general
practitioners screen smokers for COPD? So far,
there is no evidence that spirometry screening aids
smoking cessation, the single most effective mea-
sure for management of COPD.14
In a recent Danish study in general practice 54%
of COPD patients had spirometry measurement and
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50% irrespective of severity of the disease accord-
ing to GOLD.15Stable disease—treatment and follow-up
Among 119 general practitioners and 48 hospital
doctors in the county of Hordaland 88% of the
doctors preferred to treat asthma with inhalation
of b-agonists or inhalation of corticosteroids, or
both.8 The asthma treatment appeared to be in
reasonable accordance with the guidelines. There
was, however, a greater uncertainty concerning the
treating of chronic obstructive pulmonary disease.
Seventy-three percent treated them with b2-
agonists, 48% with anticholinergics and 58% with
inhaled glucocorticosteroids. Thus, the guidelines
were followed to a lower extent regarding chronic
obstructive lung disease.
The consultation rate by asthma severity was
evaluated in the European Community Respiratory
Health Survey.16 In Bergen, Norway 25% of the
subjects with a physician’s diagnosed asthma had
seen a doctor during the last year, while this was
somewhat higher in Reykjavik, Iceland (33%) and
three cities in Sweden (37%). Practically all
subjects with an attack of asthma during the last
year living in Bergen, Norway and Reykjavik,
Iceland had seen a doctor during the last year,
while only around 75% of the patients had done so
in three cities in Sweden. The frequency of
hospitalizations tended, however, to be somewhat
higher in Sweden than in Norway. This might imply
more unscheduled visits in Norway and Iceland than
in Sweden, leaving more room for educational and
preventive strategies in these countries.
In the AIRE study including patients from 7
European countries including Sweden, only 5% of
the population of patients met all the goals of the
GINA guideline.9,17 The most significant findings
were the high levels of both unscheduled emer-
gency visits and hospitalization experienced by the
asthma patients. This was underlined by a high
level of as-required use of bronchodilator medica-
tion and a low level (26%) use of anti-inflammatory
medication among patients with severe and mod-
erate persistent asthma. This suggests that asthma
may be under treated in some patients. There were
not significant differences between the countries,
although this is not reported explicitly.
There is a great variation in the prevalence of
physician diagnosed asthma and drug utilization
worldwide as observed in the European Community
Respiratory Health Survey.16 The prevalences of anti-
asthma medication were significantly below themedian in Reykjavik, Iceland and Bergen, Norway,
while this was above the median in Umea˚, Sweden. In
general, during the years 1991–1994, the highest
prevalence of inhaled bronchodilator use in the last
12 months was observed in Sweden (82%) and was
lowest in Norway (45%). The difference in use of
inhaled anti-inflammatory medication was only some-
what lower in Iceland (13%) and Norway (15%) than in
Sweden (20%), though clearly not that different as for
inhaled bronchodilators.
In another report from the Drug Education
Project (DEP) group including five European coun-
tries, among them Sweden and Norway, they
observed a variation in treatment of asthma
patients between GP’s in different countries. They
found that there was a 25–56% under-prescribing of
oral steroids, and a 21–45% over-prescribing of
antibiotics, also including Sweden and Norway.18
In a report from the DEP,19 83% of the asthma
patients in Norway and 79% of those in Sweden
received inhaled bronchodilator therapy. The cor-
responding figures for use of inhaled corticosteroids
were 45% in Sweden and 46% in Norway. Also the
knowledge about asthma treatment of exacerba-
tions and attitudes to treatment for these were
comparable. Thus, in general practice there is very
little variation in drug prescription in Sweden and
Norway among general practitioners.
An online asthma survey produced results that
agree highly with more resource demanding surveys
of treatment. Many asthmatics had a low level of
asthma control. The survey indicated that under
use of inhaled steroids was one of the reasons why
the goals set up in asthma guidelines so far have not
been reached.20
In a report from the European Community
Respiratory Health Survey,21 the characteristics of
the subjects being more likely to be treated was
addressed. There was no gender difference in
Sweden, Iceland and Norway, opposed to some
other countries where women were more likely to
be treated for the same amount of asthma-like
symptoms. Furthermore, smokers were less likely
and atopic subjects more likely to be treated with
the same amount of symptoms in the Scandinavian
countries. The odds for being treated appeared to
be higher in Sweden and Iceland compared with
Norway when presenting with the same amount of
asthma-like respiratory symptoms.Acute disease—diagnosis, treatment and
follow-up
All patients with obstructive lung disease who were
admitted to three Norwegian hospitals in a 3
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was in accordance with international guidelines.22
Altogether 176 patients were admitted of whom
60% were above 65 years of age. Thirty-one percent
had mild, 42% moderate, 21% severe and 6% life-
threatening disease. Almost all patients with
moderate and severe disease were treated with
b2 agonists on admission (Fig. 1). Among the
patients with moderate disease, 25% did not
receive glucocorticosteroids during the first 3 h in
hospital. The proportion of patients treated with
theophylline was lower among those with mild
disease than among those with moderate disease.
The authors concluded that guidelines were fol-
lowed to a high degree in patients with severe or
life-threatening obstructive lung disease, but only
partly in those with mild or moderate disease. This
was specially related to the medication with
glucocorticosteroids.
In a Danish telephone survey23 of 71 Danish
hospitals with the capacity to receive acutely ill
medical patients they observed that there was
inadequate knowledge of treatment and treatment
devices. In addition, the majority of physicians had
no specific parameters for monitoring severity of
disease. Suggestions for a practical treatment
guideline for the initial 2-h of the management of
patients with acute severe asthma and COPD have
been proposed.4,24,25 The aim is to increase the
quality of guideline and also make guideline writers
aware of the responsibility of making their recom-
mendations work.25
All hospitals in Denmark with emergency facil-
ities were surveyed in twice, 1996 and 1999.26 Even
though national guidelines were distributed,2 few
changes were observed during these years. An0
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Figure 1 Initial anti-obstructive drug treatment in 176 pat
hospitals in Western Norway in 1997, by clinical severity of dinsufficient handling of nebulizers, a huge variation
in the delivered dose of bronchodilators and a
suboptimal use of corticosteroids was found. The
study indicates a need for implementing tools for
quality control. Also in hospital doctors in Norway
the knowledge of how to use inhalation devices
should be improved.27The doctors’ and management of
patients with asthma and COPD
Wahlstrøm and coworkers28 tried to identify differ-
ences and similarities in views regarding asthma
management among general practitioners in Ger-
many, Netherlands, Sweden and Norway and ex-
plore reasons for suboptimal performance. They
aimed to develop a tailored educational interven-
tion. The majority of doctors showed confidence in
the effectiveness of the pharmaceutical treatment
of asthma. The main treatment goals were either
conceived as getting the patient symptom free
(Norway, Netherlands and Germany) or to control
inflammation (Sweden). The existence of qualita-
tively different ways of experiencing and practicing
asthma management, both in and between coun-
tries, calls for consideration when trying to imple-
ment general evidence-based treatment
guidelines. A variation of approaches in continuing
medical education of GPs is needed to address such
existing beliefs and conceptions that could some-
times be opposed to the content of educational
messages.
Many doctors has accepted the guidelines for
asthma treatment, however, the proportion of theirticosteroids Methyl xanthines
4 n = 55
Doctors’ 
assessment of 
clinical severity
Mildate
ients with obstructive lung disease acutely admitted to
isease.
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Norwegian doctors paid more attention to the
importance of the inflammatory features of asthma
than doctors from Germany and Slovakia.19 About
45% of the patient in Sweden and Norway included
in this project were treated with inhaled corticos-
teroids.
In Sweden, the GPs described qualitatively
different ways of experiencing asthma manage-
ment. The main categories were: transferring
factual knowledge to the patient, the patients’
application of knowledge in managing disease,
improving the patients’ understanding of the
disease as a prerequisite for self-management and
how to improve the patients’ quality of life despite
the asthma disease. These different approaches to
the management may have implications for the
care and educational program on asthma.29The patients’ perspective
In a Survey by general practitioners and their
patients in Norway30 about 1/3 of the patients
experienced their asthma to be uncontrolled. The
physicians tended to put more weight on respira-
tory symptoms and clinical findings, while the
patients put more weight on everyday activities
and their ability to cope with them. This was also
observed in the AIRE study where patients from
Sweden participated.9 The communication be-
tween patients and physicians including preferred
values for the patients life is thus of importance in
the process of shared decision making and chal-
lenges our traditional ways of thinking.
It appears that many patients often settle for a
quality of life considerably less than that achiev-
able if recommended management practices and
asthma treatment are used. Improving patients’
and physicians’ expectations of what can be
achieved with asthma therapy, along with imple-
mentation of guidelines, may lead to improved
overall asthma control.Management of asthma and COPD in the
community
In Finland, the Ministry of Social Affairs and Health
recognized asthma as an important public health
issue and launched in 1994 a 10 year program
emphasizing guideline implementation and follow-
up.1 This included recovery of as many patients as
possible with early asthma, that they should feel
well with ability for work and functional capacity asothers at same age, reduce the percentage of
patients with severe or moderate asthma including
hospital beds and costs per patient.31 An evaluation
in the middle of the period concluded that all goals
at least partly have been achieved. The decrease in
number of hospital beds by 50% has been fully
achieved.31 On the community level Finland has
been a leading force in Nordic national strategies
on asthma and COPD.
In Finland, the Finnish Asthma Programme has
been evaluated after 6 years. The basic structure of
equipment and organization for the diagnosis and
treatment of asthma has been set up in the primary
health services.32Strategies to improve care
An educational program for peer groups of doctors
in order to improve the treatment of asthma has
been developed.33 The DEP project group con-
cluded that improvement in asthma treatment is
possible with an educational program based on self-
learning in small groups. In this program the
Norwegian doctors improved significantly, but not
the Swedish doctors. Differences in attitudes to and
experiences with guidelines as well as with con-
tinuing medical education programs, and differ-
ences in opportunities for change, including
prevailing trends in prescribing behavior, can
explain the observed variation.33
Also other strategies to improve asthma care has
been developed and evaluated. Can the outcome of
asthma management be improved by using modern
Internet-based technology to monitor asthma pa-
tients? Three hundred asthmatic patients were
randomized to three parallel groups in a 6-month
prospective Danish study. Internet-based monitor-
ing was favorable compared with general practi-
tioner or specialist monitoring regarding symptoms,
quality of life, lung function and airway respon-
siveness.34Summary
Strategies to improve asthma management should
consider the importance of both patients’ accounts
and physiological measures, the degree of co-
operation between doctors and their patients and
eventually the ways and styles of acquiring new
knowledge about asthma.35 Also educational ap-
proaches like multidisciplinary approach for med-
ical students and self-learning groups of doctors
may be beneficial in improving management of
patients with asthma and COPD.33,36
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E. Omenaas et al.S36In practice improvement can be done by applying
more frequently good quality spirometry in diag-
nosing asthma and COPD. Regarding treatment of
obstructive lung disease there appeared to be an
under-use of glucocorticosteroids in acute as well
as in stable disease in the Nordic countries,
especially among asthmatic patients. There is still
observed an over prescription of antibiotics in
asthma patients. In COPD patients there are
uncertainty with under use of ipratropiumbromid
and inappropriate use of corticosteroids as well as
inadequate knowledge about nebulizing systems
and dosing of medicines, monitoring severity of
disease and implementing tools for quality control.
Modern Internet technology may give the patient
a better communication with doctors and disease
monitoring both in primary and secondary health
care. Telemedicine may be a new way to proceed in
improving health care for patients with asthma and
COPD.References
1. Asthma Programme in Finland 1994–2004. Clin Exp Allergy
1996;26(Suppl. 1):1–24.
2. Lange P, Hansen J, Iversen M, et al. Diagnostikk og
behandling af kronisk obstruktiv lungesygdom. Ugeskr
Laeger 1998;159(Suppl. 1):1–26.
3. Laitinen LA, Koskela K. Chronic bronchitis and chronic
obstructive pulmonary disease: Finnish National Guidelines
for Prevention and Treatment 1998–2007. Respir Med
1999;93(5):297–332.
4. Dahl R, Bjermer L. Nordic consensus report on asthma
management. Nordic Asthma Consensus Group. Respir Med
2000;94(4):299–327.
5. Global initiative for chronic obstructive lung disease (GOLD).
Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease.
Executive summary. 2004: http://www.goldcopd.com
6. Global initiative for asthma (GINA). Global strategy for
asthma management and prevention. 2004:http://www.
ginasthma.com
7. Herland K, Akselsen JP, Skjonsberg OH, Bjermer L. How
representative are clinical study patients with asthma or
COPD for a larger ‘‘real life’’ population of patients with
obstructive lung disease? Respir Med 2005;99(1):11–9.
8. Kolle S, Morkve O. Diagnosis and treatment of obstructive
lung diseases. Tidsskr Nor Laegeforen 1998;118(21):
3268–71.
9. Rabe K, Vermeire P, Soriano J, Maier W. Clinical management
of asthma in 1999: the Asthma Insights and Reality in Europe
(AIRE) study. Eur Respir J 2000;16:802–7.
10. Piirila P, Pietinalho A, Loponen M, et al. The quality of
spirometric examinations in Finland: results from a national
questionnaire survey. Clin Physiol Funct Imaging 2002;22(3):
233–9.
11. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS,
Morkve O. Risk of over-diagnosis of COPD in asymptomatic
elderly never-smokers. Eur Respir J 2002;20(5):1117–22.
12. Gudmundsson G, Gislason T, Janson C, et al. Depression,
anxiety and health status after hospitalisation for COPD: amulticentre study in the Nordic countries. Respir Med 2006;
100(1):87–93.
13. Eriksen N, Hansen EF, Munch EP, Rasmussen FV, Vestbo J.
Chronic obstructive pulmonary disease. Admission, course
and prognosis. Ugeskr Laeger 2003;165(37):3499–502.
14. Smith-Sivertsen T, Rortveit G. Should general practitioners
screen smokers for COPD? Scand J Prim Health Care
2004;22(4):196–201.
15. Moll L, Lange F, Rasmussen F, et al. Quality of COPD care in
general practice in Denmark—the KVASIMODO study. Eur
Respir J 2005;26(Suppl. 49):155.
16. Janson C, Chinn S, Jarvis D, Burney P, European Community
Respiratory Health Survey. Physician-diagnosed asthma and
drug utilization in the European Community Respiratory
Health Survey. Eur Respir J 1997;10:1795–802.
17. Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control
and differences in management practices across seven
European countries. Respir Med 2002;96(3):142–9.
18. Wahlstrom R, Hummers-Pradier E, Lundborg CS, et al.
Variations in asthma treatment in five European countries—
judgement analysis of case simulations. Fam Pract 2002;
19(5):452–60.
19. Lagerlov P, Veninga CC, Muskova M, et al. Asthma manage-
ment in five European countries: doctors’ knowledge,
attitudes and prescribing behaviour. Drug Education Project
(DEP) group. Eur Respir J 2000;15(1):25–9.
20. Janson C, Wjst M. An Internet survey of asthma treatment.
J Asthma 2004;41(1):49–55.
21. Janson C, Chinn S, Jarvis D, Burney P, On behalf of the
European Community Respiratory Health Survey. Individual
use of antiasthmatic drugs in the European Community
Respiratory Health Survey. Eur Respir J 1998;12:557–63.
22. Skaug K, Morkve O, Gulsvik A. Immediate drug therapy of
obstructive lung disease in hospital. Tidsskr Nor Laegeforen
2001;121(18):2155–8.
23. Phanareth K, Hansen EF, Laursen LC. Treatment of severe
acute exacerbation of asthma and chronic obstructive lung
disease. An interview study. Ugeskr Laeger 1997;159(47):
6985–91.
24. Phanareth K, Frausing E, Laursen LC. Standardized treat-
ment of acute severe asthma and exacerbation in chronic
obstructive pulmonary disease (COL)—a rational strategy in
the emergency department. Ugeskr Laeger 1998;160(9):
1346–7.
25. Phanareth K, Hansen LS, Christensen LK, Laursen LC. A
proposal for a practical treatment guideline designed for the
initial two-hours of the management of patients with acute
severe asthma and COPD using the principles of evidence-
based medicine. Respir Med 2002;96(9):659–71.
26. Phanareth K, Hansen LS, Christensen LK, Laursen LC, Hansen
EF. Treatment of acute severe asthma and chronic obstruc-
tive pulmonary disease in Danish hospitals. Do national
recommendations improve on the quality of the treatment?
Respir Med 2002;96(9):653–8.
27. Grydeland TB, Methlie P, Bakke PS. Hospital doctors’ and
nurses’ knowledge of how to use inhalation devices
correctly. Int J Tuberc Lung Dis 2005;9(5):586–7.
28. Wahlstrom R, Lagerlov P, Lundborg CS, et al. Variations in
general practitioners’ views of asthma management in four
European countries. Soc Sci Med 2001;53(4):507–18.
29. Lundborg CS, Wahlstrom R, Dall’Alba G. Ways of experien-
cing asthma management. Variations among general practi-
tioners in Sweden. Scand J Prim Health Care 1999;17(4):
226–31.
30. Friestad C, Øvera˚s S, Dahl E, Refvem O. Astma—slik lege og
astmatiker ser det. Nor Respir J 2001;11(02):27–35.
ARTICLE IN PRESS
Nordic physicians’ management of asthma and COPD S3731. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA.
Asthma programme in Finland: a community problem needs
community solutions. Thorax 2001;56(10):806–14.
32. Erhola M, Makinen R, Koskela K, et al. The asthma
programme of Finland: an evaluation survey in primary
health care. Int J Tuberc Lung Dis 2003;7(6):592–8.
33. Veninga CC, Lagerlov P, Wahlstrom R, et al. Evaluating an
educational intervention to improve the treatment of
asthma in four European countries. Drug Education
Project Group. Am J Respir Crit Care Med 1999;160(4):
1254–62.34. Rasmussen LM, Phanareth K, Nolte H, Backer V. Internet-
based monitoring of asthma: a long-term, randomized
clinical study of 300 asthmatic subjects. J Allergy Clin
Immunol 2005;115(6):1137–42.
35. Lagerlov P, Leseth A, Matheson I. The doctor–patient
relationship and the management of asthma. Soc Sci Med
1998;47(1):85–91.
36. Smith-Sivertsen T, Rortveit G, Gulsvik A, Bakke PS, Skadberg
B. An interdisciplinary educational program about pulmon-
ary obstructive disease in family practice. Tidsskr Nor
Laegeforen 2005;125(4):465.
